论文部分内容阅读
非那雄胺治疗男性秃发 非那雄胺(finasteride,商品名Propecia)是一种具有口服活性的选择性睾酮5-α还原酶Ⅱ型抑制剂,原属抗肿瘤药物。继1998年9月被瑞典批准后,现已有8个欧洲国家批准上市,用于治疗男性秃发。法国已于1999年2月开始作为非补偿处方药物予以零售,估计每月治疗费约在54～62美元。该药还可用于良性前列腺肥大。 US批准单用拉莫三嗪治疗癫痫 拉莫三嗪(lamotrigine(商品名Lamictal)1994年被批准与其它抗惊厥药合用辅助治疗癫痫,美国已拓展了它的应用,即单独应用该药治疗某
Finasteride treatment Male bald finasteride (finasteride, trade name Propecia) is an orally active selective testosterone 5-α reductase type inhibitor, the original anti-tumor drugs. Following the approval of Sweden in September 1998, eight European countries are now approved for the treatment of male alopecia. France began retail as a non-compensatory prescription drug in February 1999 and estimated monthly treatment costs ranged from 54 to 62 U.S. dollars. This medicine can also be used for benign prostatic hypertrophy. US Approved Single Lamivudine for the Treatment of Epilepsy Lamotrigine (Lamictal) was approved in 1994 for adjuvant treatment of epilepsy in combination with other anticonvulsants. The United States has broadened its use of the drug alone for the treatment of certain